Biogen charge cuts pressure benefit beat, Alzheimer's drug gross sales soar
By way of Manas Mishra and Sriparna Roy(Reuters) -Biogen beat marketplace estimates for first-quarter benefit on Wednesday as a sequence of cost-cutting measures helped offset the affect of fierce pageant for its